22393-62-0_peak 2

CAS No. 22393-63-1

22393-62-0_peak 2( —— )

Catalog No. M37665 CAS No. 22393-63-1

22393-62-0_peak 2 exhibits some aspects of the antiestrogenic activity and other actions that may be connected to the estrogenic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    22393-62-0_peak 2
  • Note
    Research use only, not for human use.
  • Brief Description
    22393-62-0_peak 2 exhibits some aspects of the antiestrogenic activity and other actions that may be connected to the estrogenic properties.
  • Description
    22393-62-0_peak 2 exhibits some aspects of the antiestrogenic activity and other actions that may be connected to the estrogenic properties. A mixture of the (Z)- and (E)-isomers (Broparestrol, INN) is used in dermatology.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22393-63-1
  • Formula Weight
    363.29
  • Molecular Formula
    C22H19Br
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C(\Br)/C1=CC=CC=C1)(\C2=CC=C(CC)C=C2)/C3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Prasugrel Hydrochlor...

    Prasugrel hydrochloride is a piperazine derivative and pletelet aggregation inhibitor that is used to prevent thrombosis in patients with acute coronary syndrome.

  • LEM-14-1189 B

    Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 μM, 111 μM, and 60 μM, respectively.

  • Gymnemagenin

    Gymnemagenin is a potent and selective antagonist for the β isoform of LXR it has antihyperglycemic activity.